« BackThe Breast
Article in Press

WITHDRAWN: Combined epirubicin and vinorelbine as first-line therapy in metastatic breast cancer: a pilot study performed by the Danish Breast Cancer Cooperative Group

Department of Oncology, The Finsen Center, Rigshospitalet Bldg. 5012, Blegdamsvej 9, DK-2100 Copenhagen Ø, Denmark; Department of Oncology, Aarhus University Hospital, Nørrebrogade 44, DK-8000 Aarhus C, Denmark; Department of Oncology, Odense University Hospital, Sdr. Boulevard 29, DK-5000 Odense C, Denmark; Department of Oncology, Aalborg Hospital Syd, Hobrovej 18-22, DK-9100 Aalborg, Denmark

published online 31 May 2007.
Corrected Proof

The publisher regrets that this is an accidental duplication of an article that has already been published in The Breast, 12 (2003) 42–50, doi:10.1016/S0960-9776(02)00180-7. The duplicate article has therefore been withdrawn.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0960-9776(02)90469-8

doi:10.1054/brst.2002.0469

« BackThe Breast

Article Tools